APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioabsorbable Sirolimus-eluting Coronary Stent System

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025182 pages

Choose your research edition.

Industry ResearchBioabsorbable Sirolimus-eluting Coronary Stent System Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioabsorbable Sirolimus-eluting Coronary Stent System Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioabsorbable Sirolimus-eluting Coronary Stent System Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bioabsorbable Sirolimus-eluting Coronary Stent System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bioabsorbable Sirolimus-eluting Coronary Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioabsorbable Sirolimus-eluting Coronary Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioabsorbable Sirolimus-eluting Coronary Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bioabsorbable Sirolimus-eluting Coronary Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bioabsorbable Sirolimus-eluting Coronary Stent System include Micell Technologies Ireland, Q3 Medical, Bioheart, Lepu, Shandong Huaan Biotechnology and MicroPort, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bioabsorbable Sirolimus-eluting Coronary Stent System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioabsorbable Sirolimus-eluting Coronary Stent System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioabsorbable Sirolimus-eluting Coronary Stent System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bioabsorbable Sirolimus-eluting Coronary Stent System market size, projected growth trends, production technologies, key applications, and end-use industries.

Bioabsorbable Sirolimus-eluting Coronary Stent System Segment by Company

Micell Technologies Ireland

Q3 Medical

Bioheart

Lepu

Shandong Huaan Biotechnology

MicroPort

Bioabsorbable Sirolimus-eluting Coronary Stent System Segment by Type

Polylactic Acid (PLA)

Polyglycolic Acid (PGA)

Bioabsorbable Sirolimus-eluting Coronary Stent System Segment by Application

Hospital

Clinic

Bioabsorbable Sirolimus-eluting Coronary Stent System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioabsorbable Sirolimus-eluting Coronary Stent System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioabsorbable Sirolimus-eluting Coronary Stent System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioabsorbable Sirolimus-eluting Coronary Stent System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bioabsorbable Sirolimus-eluting Coronary Stent System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bioabsorbable Sirolimus-eluting Coronary Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bioabsorbable Sirolimus-eluting Coronary Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bioabsorbable Sirolimus-eluting Coronary Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Trends Table 2. Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Drivers Table 3. Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Opportunities and Challenges Table 4. Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Restraints Table 5. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Manufacturers Table 9. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Manufacturers, Product Type & Application Table 13. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bioabsorbable Sirolimus-eluting Coronary Stent System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polylactic Acid (PLA) Table 17. Major Manufacturers of Polyglycolic Acid (PGA) Table 18. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type (2021-2026) & (K Units) Table 20. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type (2027-2032) & (K Units) Table 21. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Type (2021-2026) Table 22. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Type (2027-2032) Table 23. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type (2021-2026) & (K Units) Table 25. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type (2027-2032) & (K Units) Table 26. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Type (2021-2026) Table 27. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application (2021-2026) & (K Units) Table 32. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application (2027-2032) & (K Units) Table 33. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Application (2021-2026) Table 34. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Application (2027-2032) Table 35. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application (2021-2026) & (K Units) Table 37. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application (2027-2032) & (K Units) Table 38. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Application (2021-2026) Table 39. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Application (2027-2032) Table 40. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region (2021-2026) & (K Units) Table 42. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Region (2021-2026) Table 43. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2026) & (K Units) Table 47. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2027-2032) & (K Units) Table 48. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2026) & (K Units) Table 50. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2027-2032) & (K Units) Table 57. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Region (2021-2026) Table 61. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Region (2027-2032) Table 62. Micell Technologies Ireland Company Information Table 63. Micell Technologies Ireland Business Overview Table 64. Micell Technologies Ireland Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Micell Technologies Ireland Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 66. Micell Technologies Ireland Recent Development Table 67. Q3 Medical Company Information Table 68. Q3 Medical Business Overview Table 69. Q3 Medical Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Q3 Medical Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 71. Q3 Medical Recent Development Table 72. Bioheart Company Information Table 73. Bioheart Business Overview Table 74. Bioheart Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bioheart Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 76. Bioheart Recent Development Table 77. Lepu Company Information Table 78. Lepu Business Overview Table 79. Lepu Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Lepu Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 81. Lepu Recent Development Table 82. Shandong Huaan Biotechnology Company Information Table 83. Shandong Huaan Biotechnology Business Overview Table 84. Shandong Huaan Biotechnology Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Shandong Huaan Biotechnology Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 86. Shandong Huaan Biotechnology Recent Development Table 87. MicroPort Company Information Table 88. MicroPort Business Overview Table 89. MicroPort Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. MicroPort Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio Table 91. MicroPort Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Bioabsorbable Sirolimus-eluting Coronary Stent System Distributors List Table 95. Bioabsorbable Sirolimus-eluting Coronary Stent System Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Bioabsorbable Sirolimus-eluting Coronary Stent System Product Image Figure 2. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales (2021-2032) & (K Units) Figure 5. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bioabsorbable Sirolimus-eluting Coronary Stent System Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polylactic Acid (PLA) Image Figure 9. Polyglycolic Acid (PGA) Image Figure 10. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Type (2021-2032) Figure 13. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Application (2021-2032) Figure 21. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Application (2021-2032) Figure 24. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Country (2021-2032) Figure 26. U.S. Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Country (2021-2032) Figure 31. Germany Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Country (2021-2032) Figure 38. China Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Country (2021-2032) Figure 46. Brazil Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Bioabsorbable Sirolimus-eluting Coronary Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032) & (US$ Million) Figure 57. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032) & (US$ Million) Figure 59. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Bioabsorbable Sirolimus-eluting Coronary Stent System Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Bioabsorbable Sirolimus-eluting Coronary Stent System Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
Applications
  • Hospital
  • Clinic
Companies covered
  • Micell Technologies Ireland
  • Q3 Medical
  • Bioheart
  • Lepu
  • Shandong Huaan Biotechnology
  • MicroPort

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Dynamics
  1. 2.1 Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Trends
  2. 2.2 Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Drivers
  3. 2.3 Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Opportunities and Challenges
  4. 2.4 Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Restraints
3 Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Manufacturers
  1. 3.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Manufacturers, Product Type & Application
  7. 3.7 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bioabsorbable Sirolimus-eluting Coronary Stent System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bioabsorbable Sirolimus-eluting Coronary Stent System Tier 1, Tier 2, and Tier 3
4 Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Type
  1. 4.1 Bioabsorbable Sirolimus-eluting Coronary Stent System Type Introduction
  2. 4.1.1 Polylactic Acid (PLA)
  3. 4.1.2 Polyglycolic Acid (PGA)
  4. 4.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type
  5. 4.2.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Type (2021-2032)
  7. 4.2.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type
  9. 4.3.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Type (2021-2032)
  11. 4.3.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Type (2021-2032)
5 Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Application
  1. 5.1 Bioabsorbable Sirolimus-eluting Coronary Stent System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application
  5. 5.2.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Application (2021-2032)
  7. 5.2.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application
  9. 5.3.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Application (2021-2032)
  11. 5.3.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Application (2021-2032)
6 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region
  1. 6.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region (2021-2032)
  3. 6.2.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Region (2021-2026)
  4. 6.2.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region
  1. 7.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region
  2. 7.1.1 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region (2021-2026)
  4. 7.1.3 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue by Region (2027-2032)
  5. 7.1.4 Global Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032)
  8. 7.2.2 North America Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032)
  11. 7.3.2 Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Micell Technologies Ireland
  2. 8.1.1 Micell Technologies Ireland Company Information
  3. 8.1.2 Micell Technologies Ireland Business Overview
  4. 8.1.3 Micell Technologies Ireland Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Micell Technologies Ireland Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  6. 8.1.5 Micell Technologies Ireland Recent Developments
  7. 8.2 Q3 Medical
  8. 8.2.1 Q3 Medical Company Information
  9. 8.2.2 Q3 Medical Business Overview
  10. 8.2.3 Q3 Medical Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Q3 Medical Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  12. 8.2.5 Q3 Medical Recent Developments
  13. 8.3 Bioheart
  14. 8.3.1 Bioheart Company Information
  15. 8.3.2 Bioheart Business Overview
  16. 8.3.3 Bioheart Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bioheart Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  18. 8.3.5 Bioheart Recent Developments
  19. 8.4 Lepu
  20. 8.4.1 Lepu Company Information
  21. 8.4.2 Lepu Business Overview
  22. 8.4.3 Lepu Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lepu Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  24. 8.4.5 Lepu Recent Developments
  25. 8.5 Shandong Huaan Biotechnology
  26. 8.5.1 Shandong Huaan Biotechnology Company Information
  27. 8.5.2 Shandong Huaan Biotechnology Business Overview
  28. 8.5.3 Shandong Huaan Biotechnology Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Huaan Biotechnology Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  30. 8.5.5 Shandong Huaan Biotechnology Recent Developments
  31. 8.6 MicroPort
  32. 8.6.1 MicroPort Company Information
  33. 8.6.2 MicroPort Business Overview
  34. 8.6.3 MicroPort Bioabsorbable Sirolimus-eluting Coronary Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MicroPort Bioabsorbable Sirolimus-eluting Coronary Stent System Product Portfolio
  36. 8.6.5 MicroPort Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bioabsorbable Sirolimus-eluting Coronary Stent System Value Chain Analysis
  2. 9.1.1 Bioabsorbable Sirolimus-eluting Coronary Stent System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bioabsorbable Sirolimus-eluting Coronary Stent System Production Mode & Process
  6. 9.2 Bioabsorbable Sirolimus-eluting Coronary Stent System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bioabsorbable Sirolimus-eluting Coronary Stent System Distributors
  9. 9.2.3 Bioabsorbable Sirolimus-eluting Coronary Stent System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst